Acadian Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$143M Buy
2,043,850
+1,961,764
+2,390% +$137M 0.29% 80
2025
Q1
$6.03M Sell
82,086
-48,052
-37% -$3.53M 0.02% 450
2024
Q4
$8.52M Sell
130,138
-386,039
-75% -$25.3M 0.02% 396
2024
Q3
$40.2M Buy
516,177
+504,652
+4,379% +$39.3M 0.12% 170
2024
Q2
$897K Sell
11,525
-808
-7% -$62.9K ﹤0.01% 1031
2024
Q1
$834K Sell
12,333
-13,927
-53% -$942K ﹤0.01% 892
2023
Q4
$1.77M Sell
26,260
-13,552
-34% -$911K 0.01% 699
2023
Q3
$2.69M Sell
39,812
-86,442
-68% -$5.84M 0.01% 603
2023
Q2
$9.03M Buy
126,254
+92,277
+272% +$6.6M 0.04% 316
2023
Q1
$2.35M Sell
33,977
-24,444
-42% -$1.69M 0.01% 661
2022
Q4
$3.96M Buy
58,421
+38,912
+199% +$2.63M 0.02% 509
2022
Q3
$1.07M Buy
19,509
+15,125
+345% +$827K 0.01% 790
2022
Q2
$289K Buy
4,384
+3,861
+738% +$255K ﹤0.01% 1111
2022
Q1
$34K Sell
523
-21,916
-98% -$1.42M ﹤0.01% 1508
2021
Q4
$1.31M Sell
22,439
-55,741
-71% -$3.25M ﹤0.01% 766
2021
Q3
$4.69M Sell
78,180
-70,329
-47% -$4.22M 0.02% 462
2021
Q2
$8.9M Sell
148,509
-49,741
-25% -$2.98M 0.03% 336
2021
Q1
$9.86M Sell
198,250
-151,015
-43% -$7.51M 0.04% 336
2020
Q4
$17.5M Buy
349,265
+116,244
+50% +$5.81M 0.07% 242
2020
Q3
$12.8M Buy
+233,021
New +$12.8M 0.05% 277
2018
Q3
Sell
-2,162
Closed -$76K 1659
2018
Q2
$76K Sell
2,162
-3,212
-60% -$113K ﹤0.01% 1306
2018
Q1
$188K Sell
5,374
-602,290
-99% -$21.1M ﹤0.01% 1072
2017
Q4
$21.1M Sell
607,664
-720,513
-54% -$25M 0.09% 189
2017
Q3
$45M Sell
1,328,177
-188,909
-12% -$6.4M 0.2% 121
2017
Q2
$51.7M Sell
1,517,086
-66,265
-4% -$2.26M 0.23% 106
2017
Q1
$49.3M Buy
1,583,351
+1,494,725
+1,687% +$46.5M 0.23% 107
2016
Q4
$2.42M Hold
88,626
0.01% 551
2016
Q3
$2.91M Buy
+88,626
New +$2.91M 0.01% 452
2014
Q4
Sell
-1,084
Closed -$39K 1265
2014
Q3
$39K Sell
1,084
-1,496
-58% -$53.8K ﹤0.01% 879
2014
Q2
$96K Sell
2,580
-3,674
-59% -$137K ﹤0.01% 865
2014
Q1
$203K Buy
6,254
+36
+0.6% +$1.17K ﹤0.01% 778
2013
Q4
$185K Sell
6,218
-802
-11% -$23.9K ﹤0.01% 814
2013
Q3
$182K Buy
7,020
+418
+6% +$10.8K ﹤0.01% 757
2013
Q2
$156K Buy
+6,602
New +$156K ﹤0.01% 702